CompletedNot applicableNCT02556840

Impact on Birth Weight of Two Therapeutic Strategies (Insulin Therapy From the Beginning of Pregnancy vs. Insulin Therapy Initiated According to Fetal Growth Evaluated by Ultrasonography Measurements) in Pregnant Women With Monogenic Diabetes

Studying MODY

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Assistance Publique - Hôpitaux de Paris
Principal Investigator
Christine Bellanné-Chantelot, PharmaD, PhD
Assistance Publique - Hôpitaux de Paris
Intervention
insulin therapy(other)
Enrollment
46 target
Eligibility
18 years · FEMALE
Timeline
20162020

Study locations (1)

Collaborators

URC-CIC Paris Descartes Necker Cochin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02556840 on ClinicalTrials.gov

Other trials for MODY

Additional recruiting or active studies for the same condition.

See all trials for MODY

← Back to all trials